From €2209EUR$2,490USD£1,928GBP
- Report
- May 2025
- 200 Pages
Saudi Arabia
From €2209EUR$2,490USD£1,928GBP
- Report
- February 2025
- 70 Pages
China
From €2209EUR$2,490USD£1,928GBP
- Report
- August 2024
- 200 Pages
Global
From €2209EUR$2,490USD£1,928GBP
- Report
- September 2023
- 170 Pages
Global
From €1765EUR$1,990USD£1,541GBP
- Report
- September 2023
- 190 Pages
Global
From €2209EUR$2,490USD£1,928GBP
- Report
- July 2023
- 220 Pages
Asia Pacific
From €1765EUR$1,990USD£1,541GBP
- Report
- July 2023
- 210 Pages
Global
From €1765EUR$1,990USD£1,541GBP
- Report
- April 2023
- 275 Pages
Global
From €3540EUR$3,990USD£3,090GBP
- Report
- April 2023
- 450 Pages
Global
From €2653EUR$2,990USD£2,315GBP
- Report
- January 2023
- 115 Pages
Global
From €2209EUR$2,490USD£1,928GBP
- Report
- October 2020
- 100 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €1943EUR$2,190USD£1,696GBP
- Report
- October 2020
- 100 Pages
China
From €1765EUR$1,990USD£1,541GBP
- Report
- April 2018
- 126 Pages
Canada
From €1677EUR$1,890USD£1,464GBP
- Report
- October 2025
- 21 Pages
Germany
- Report
- October 2025
- 23 Pages
United States
- Report
- October 2025
- 8 Pages
United States
- Report
- October 2025
United States
- Report
- October 2025
- 21 Pages
France
- Report
- October 2025
- 21 Pages
Italy

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more